Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program
Go back to Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 154.06 -1.86 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $155.92 | 52 Week High | $58.46 | |||
| Open | $155.92 | 52 Week Low | $31.25 | |||
| Day High | $156.57 | P/E | N/A | |||
| Day Low | $153.08 | EPS | $-0.69 | |||
| Volume | 812,988 | |||||
| (NASDAQ: VYGR) | Delayed: 3.54 +0.08 (2.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.46 | 52 Week High | $30.54 | |||
| Open | $3.47 | 52 Week Low | $8.12 | |||
| Day High | $3.56 | P/E | N/A | |||
| Day Low | $3.36 | EPS | $0.00 | |||
| Volume | 406,269 | |||||
